# CRISPR-Based Gene Editing Efficiency Analysis _Example research report — demonstrates markdown-mermaid-writing skill standards. All diagrams use Mermaid embedded in markdown as the source format._ --- ## 📋 Overview This report analyzes the efficiency of CRISPR-Cas9 gene editing across three cell line models under variable guide RNA (gRNA) conditions. Editing efficiency was quantified by T7E1 assay and next-generation sequencing (NGS) of on-target loci[^1]. **Key findings:** - HEK293T cells show highest editing efficiency (mean 78%) across all gRNA designs - GC content between 40–65% correlates with editing efficiency (r = 0.82) - Off-target events occur at <0.1% frequency across all conditions tested --- ## 🔄 Experimental workflow CRISPR editing experiments followed a standardized five-stage protocol. Each stage has defined go/no-go criteria before proceeding. ```mermaid flowchart TD accTitle: CRISPR Editing Experimental Workflow accDescr: Five-stage experimental pipeline from gRNA design through data analysis, with quality checkpoints between each stage. design["🧬 Stage 1
gRNA Design
(CRISPRscan + Cas-OFFinder)"] synth["⚙️ Stage 2
Oligo Synthesis
& Annealing"] transfect["🔬 Stage 3
Cell Transfection
(Lipofectamine 3000)"] screen["🧪 Stage 4
Primary Screen
(T7E1 assay)"] ngs["📊 Stage 5
NGS Validation
(150 bp PE reads)"] qc1{GC 40-65%?} qc2{Yield ≥ 2 µg?} qc3{Viability ≥ 85%?} qc4{Band visible?} design --> qc1 qc1 -->|"✅ Pass"| synth qc1 -->|"❌ Redesign"| design synth --> qc2 qc2 -->|"✅ Pass"| transfect qc2 -->|"❌ Re-synthesize"| synth transfect --> qc3 qc3 -->|"✅ Pass"| screen qc3 -->|"❌ Optimize"| transfect screen --> qc4 qc4 -->|"✅ Pass"| ngs qc4 -->|"❌ Repeat"| screen classDef stage fill:#dbeafe,stroke:#2563eb,stroke-width:2px,color:#1e3a5f classDef gate fill:#fef9c3,stroke:#ca8a04,stroke-width:2px,color:#713f12 classDef fail fill:#fee2e2,stroke:#dc2626,stroke-width:2px,color:#7f1d1d class design,synth,transfect,screen,ngs stage class qc1,qc2,qc3,qc4 gate ``` --- ## 🔬 Methods ### Cell lines and culture Three cell lines were used: HEK293T (human embryonic kidney), K562 (chronic myelogenous leukemia), and Jurkat (T-lymphocyte). All lines were maintained in RPMI-1640 with 10% FBS at 37°C / 5% CO₂[^2]. ### gRNA design and efficiency prediction gRNAs targeting the _EMX1_ locus were designed using CRISPRscan[^3] with the following criteria: | Criterion | Threshold | Rationale | | -------------------- | --------- | ------------------------------------- | | GC content | 40–65% | Optimal Tm and Cas9 binding | | CRISPRscan score | ≥ 0.6 | Predicted on-target activity | | Off-target sites | ≤ 5 (≤3 mismatches) | Reduce off-target editing risk | | Homopolymer runs | None (>4 nt) | Prevents premature transcription stop | ### Transfection protocol RNP complexes were assembled at 1:1.2 molar ratio (Cas9:gRNA) and delivered by lipofection. Cells were harvested 72 hours post-transfection for genomic DNA extraction. ### Analysis pipeline ```mermaid sequenceDiagram accTitle: NGS Data Analysis Pipeline accDescr: Sequence of computational steps from raw FASTQ files through variant calling to final efficiency report. participant raw as 📥 Raw FASTQ participant qc as 🔍 FastQC participant trim as ✂️ Trimmomatic participant align as 🗺️ BWA-MEM2 participant call as ⚙️ CRISPResso2 participant report as 📊 Report raw->>qc: Per-base quality scores qc-->>trim: Flag low-Q reads (Q<20) trim->>align: Cleaned reads align->>align: Index reference genome (hg38) align->>call: BAM + target region BED call->>call: Quantify indel frequency call-->>report: Editing efficiency (%) call-->>report: Off-target events report-->>report: Statistical summary ``` --- ## 📊 Results ### Editing efficiency by cell line | Cell line | n (replicates) | Mean efficiency (%) | SD (%) | Range (%) | | ---------- | -------------- | ------------------- | ------ | --------- | | **HEK293T** | 6 | **78.4** | 4.2 | 71.2–84.6 | | K562 | 6 | 52.1 | 8.7 | 38.4–63.2 | | Jurkat | 6 | 31.8 | 11.3 | 14.2–47.5 | HEK293T cells showed significantly higher editing efficiency than both K562 (p < 0.001) and Jurkat (p < 0.001) lines by one-way ANOVA with Tukey post-hoc correction. ### Effect of GC content on efficiency GC content between 40–65% was strongly correlated with editing efficiency (Pearson r = 0.82, p < 0.0001, n = 48 gRNAs). ```mermaid xychart-beta accTitle: Editing Efficiency vs gRNA GC Content accDescr: Bar chart showing mean editing efficiency grouped by GC content bins, demonstrating optimal performance in the 40 to 65 percent GC range title "Mean Editing Efficiency by GC Content Bin (HEK293T)" x-axis ["< 30%", "30–40%", "40–50%", "50–65%", "> 65%"] y-axis "Editing Efficiency (%)" 0 --> 100 bar [18, 42, 76, 81, 38] ``` ### Timeline of key experimental milestones ```mermaid timeline accTitle: Experiment Timeline — CRISPR Efficiency Study accDescr: Chronological milestones from study design through manuscript submission across six months section Month 1 Study design and gRNA library design : 48 gRNAs across 3 target loci Cell line authentication : STR profiling confirmed all three lines section Month 2 gRNA synthesis and QC : 46/48 gRNAs passed yield threshold Pilot transfections (HEK293T) : Optimized lipofection conditions section Month 3 Full transfection series : All 3 cell lines, all 46 gRNAs, 6 replicates T7E1 primary screening : Passed go/no-go for all conditions section Month 4 NGS library preparation : 276 samples processed Sequencing run (NovaSeq) : 150 bp PE, mean 50k reads/sample section Month 5 Bioinformatic analysis : CRISPResso2 pipeline Statistical analysis : ANOVA, correlation, regression section Month 6 Manuscript preparation : This report ``` --- ## 🔍 Discussion ### Why HEK293T outperforms suspension lines HEK293T's superior editing efficiency relative to K562 and Jurkat likely reflects three factors[^4]: 1. **Adherent morphology** — enables more uniform lipofection contact 2. **High transfection permissiveness** — HEK293T expresses the SV40 large T antigen, which may facilitate nuclear import 3. **Cell cycle distribution** — higher proportion in S/G2 phase where HDR is favored

🔧 Technical details — off-target analysis

Off-target editing was assessed by GUIDE-seq at the 5 highest-activity gRNAs. No off-target sites exceeding 0.1% editing frequency were detected. The three potential sites flagged by Cas-OFFinder (≤2 mismatches) showed 0.00%, 0.02%, and 0.04% indel frequencies — all below the assay noise floor of 0.05%. Full GUIDE-seq data available in supplementary data package (GEO accession pending).

--- ### Comparison with published benchmarks _Radar chart comparing three CRISPR delivery methods across five performance dimensions. Note: Radar charts do not support `accTitle`/`accDescr` — description provided above._ ```mermaid radar-beta title Performance vs. Published Methods axis eff["Efficiency"], spec["Specificity"], del["Delivery ease"], cost["Cost"], viab["Cell viability"] curve this_study["This study (RNP + Lipo)"]{78, 95, 80, 85, 90} curve plasmid["Plasmid Cas9 (lit.)"]{55, 70, 90, 95, 75} curve electroporation["Electroporation RNP (lit.)"]{88, 96, 50, 60, 65} max 100 graticule polygon ticks 5 showLegend true ``` --- ## 🎯 Conclusions 1. RNP-lipofection in HEK293T achieves >75% CRISPR editing efficiency — competitive with electroporation without the associated viability cost 2. gRNA GC content is the single strongest predictor of editing efficiency in our dataset (r = 0.82) 3. This protocol is not directly transferable to suspension lines without further optimization; K562 and Jurkat require electroporation or viral delivery for comparable efficiency --- ## 🔗 References [^1]: Ran, F.A. et al. (2013). "Genome engineering using the CRISPR-Cas9 system." _Nature Protocols_, 8(11), 2281–2308. https://doi.org/10.1038/nprot.2013.143 [^2]: ATCC. (2024). "Cell Line Authentication and Quality Control." https://www.atcc.org/resources/technical-documents/cell-line-authentication [^3]: Moreno-Mateos, M.A. et al. (2015). "CRISPRscan: designing highly efficient sgRNAs for CRISPR-Cas9 targeting in vivo." _Nature Methods_, 12(10), 982–988. https://doi.org/10.1038/nmeth.3543 [^4]: Molla, K.A. & Yang, Y. (2019). "CRISPR/Cas-Mediated Base Editing: Technical Considerations and Practical Applications." _Trends in Biotechnology_, 37(10), 1121–1142. https://doi.org/10.1016/j.tibtech.2019.03.008